ClearPoint Neuro, Inc. Long-Term Debt
ClearPoint Neuro, Inc. (CLPT) had Long-Term Debt of $822.01 thousand as of 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2020-11-12
- 2020-09-30: Long-term Debt, Excluding Current Maturities $822.01K.
- 2020-06-30: Long-term Debt, Excluding Current Maturities $599.32K.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2020-09-30 | $822.01K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $599.32K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |